Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AUGX Augmedix (AUGX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends About Augmedix Stock (NASDAQ:AUGX) 30 days 90 days 365 days Advanced Chart Ad Chaikin AnalyticsNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...Not everything is as rosy as it seems on Wall Street. Get Augmedix alerts:Sign Up Key Stats Today's Range$2.35▼$2.3550-Day Range$2.29▼$2.3552-Week Range$0.73▼$6.25VolumeN/AAverage Volume635,746 shsMarket Capitalization$115.07 millionP/E RatioN/ADividend YieldN/APrice Target$3.09Consensus RatingHold Company OverviewAugmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.Read More… New post-election stock warning from Wall Street (Ad)If you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...Not everything is as rosy as it seems on Wall Street. Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Email Address AUGX Stock News HeadlinesCommure Completes Merger with AugmedixOctober 2, 2024 | globenewswire.com7 AI Penny Stocks to Watch in OctoberSeptember 27, 2024 | 247wallst.com50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. November 23, 2024 | Chaikin Analytics (Ad)STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Looming Vote on September 27, 2024, of Augmedix, Inc. - AUGXSeptember 6, 2024 | prnewswire.comAUGX Sep 2024 2.500 putAugust 18, 2024 | ca.finance.yahoo.comAUGX Sep 2024 2.500 callAugust 17, 2024 | ca.finance.yahoo.comAUGX Sep 2024 7.500 callAugust 17, 2024 | ca.finance.yahoo.comAUGX Stock Earnings: Augmedix Misses EPS, Misses Revenue for Q2 2024August 12, 2024 | investorplace.comSee More Headlines AUGX Stock Analysis - Frequently Asked Questions When did Augmedix IPO? Augmedix (AUGX) raised $40 million in an initial public offering on Tuesday, October 26th 2021. The company issued 10,000,000 shares at a price of $4.00 per share. William Blair, B. Riley Securities, Benchmark and Lake Street acted as the underwriters for the IPO. Who are Augmedix's major shareholders? Top institutional shareholders of Augmedix include Trium Capital LLP (2.41%), HGC Investment Management Inc. (1.69%), Geode Capital Management LLC (1.14%) and State Street Corp (0.31%). Insiders that own company stock include Paul Ginocchio, Emmanuel Krakaris, Ian Shakil and Saurav Chatterjee. View institutional ownership trends. What other stocks do shareholders of Augmedix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Novo Nordisk A/S (NVO). Company Calendar Today11/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business services, not elsewhere classified Sub-IndustryBusiness Services Current SymbolNASDAQ:AUGX CUSIPN/A CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees1,430Year FoundedN/APrice Target and Rating Average Stock Price Target$3.09 High Stock Price Target$5.00 Low Stock Price Target$1.50 Potential Upside/Downside+31.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,170,000.00 Net Margins-46.23% Pretax Margin-46.10% Return on Equity-182.36% Return on Assets-43.21% Debt Debt-to-Equity Ratio1.48 Current Ratio1.66 Quick Ratio1.66 Sales & Book Value Annual Sales$51.58 million Price / Sales2.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.56 per share Price / Book4.20Miscellaneous Outstanding Shares48,968,000Free Float43,596,000Market Cap$115.07 million OptionableOptionable Beta-0.22 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report This page (NASDAQ:AUGX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.